Clinical Trial Update: Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing docetaxel plus plinabulin versus docetaxel plus placebo in advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Plinabulin (plinabulin)

Snippet

Sponsor: BeyondSpring Pharmaceuticals Inc. | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED